title: Risk of false positive results to SARM S-4 in case of therapeutic use of antineoplastic/antiandrogen drug containing flutamide: a case study.
authors: Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Chemin des Croisettes 22, 1066, Epalinges, Switzerland.
authors: L
authors: L
authors: Perrenoud
authors: Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Chemin des Croisettes 22, 1066, Epalinges, Switzerland.
authors: C
authors: C
authors: Schweizer Grundisch
authors: Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Chemin des Croisettes 22, 1066, Epalinges, Switzerland.
authors: N
authors: N
authors: Baume
authors: Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Chemin des Croisettes 22, 1066, Epalinges, Switzerland.
authors: M
authors: M
authors: Saugy
authors: Swiss Laboratory for Doping Analyses, University Center of Legal Medicine Lausanne-Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Chemin des Croisettes 22, 1066, Epalinges, Switzerland.
authors: R
authors: R
authors: Nicoli
mesh_terms: D000726:Androgen Antagonists / Q000737:chemistry* / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000737:chemistry*; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use*; D005485:Flutamide / Q000737:chemistry* / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000726:Androgen Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000970:Antineoplastic Agents; D005485:Flutamide